{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:53:28Z","timestamp":1785894808212,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41440-022-00948-7","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T11:20:53Z","timestamp":1654773653000},"page":"1418-1429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prevalence and clinical characteristics of primary aldosteronism in a tertiary-care center in Korea"],"prefix":"10.1038","volume":"45","author":[{"given":"Minjae","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyung","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheol Ryong","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungha","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"948_CR1","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"948_CR2","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin P-F, Blacher J, Safar ME, Mourad J-J. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"948_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone S, D\u2019Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6:41\u201350.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"948_CR4","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, et al. Long-term cardio-and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98:4826\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"948_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","volume":"62","author":"GP Rossi","year":"2013","unstructured":"Rossi GP, Cesari M, Cuspidi C, Maiolino G, Cicala MV, Bisogni V, et al. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension. 2013;62:62\u20139.","journal-title":"Hypertension."},{"key":"948_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008;168:80\u20135.","journal-title":"Arch Intern Med"},{"key":"948_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","volume":"66","author":"NM Kaplan","year":"1967","unstructured":"Kaplan NM. Hypokalemia in the hypertensive patient: with observations on the incidence of primary aldosteronism. Ann Intern Med. 1967;66:1079\u201390.","journal-title":"Ann Intern Med"},{"key":"948_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jama.1968.03140330039007","volume":"205","author":"LM Fishman","year":"1968","unstructured":"Fishman LM, K\u00fcchel O, Liddle GW, Michelakis AM, Gordon RD, Chick WT. Incidence of primary aldosteronism uncomplicated essential hypertension: a prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria. JAMA. 1968;205:497\u2013502.","journal-title":"JAMA"},{"key":"948_CR9","first-page":"187","volume":"2","author":"G Andersen","year":"1988","unstructured":"Andersen G, Toftdahl D, Lund J, Strandgaard S, Nielsen P. The incidence rate of phaeochromocytoma and Conn\u2019s syndrome in Denmark, 1977\u20131981. J Hum Hypertens. 1988;2:187\u20139.","journal-title":"J Hum Hypertens"},{"key":"948_CR10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh K-C, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"948_CR11","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293\u2013300.","journal-title":"J Am Coll Cardiol"},{"key":"948_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1055\/s-0031-1295438","volume":"44","author":"A Hannemann","year":"2012","unstructured":"Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies\u2013a review of the current literature. Horm Metab Res. 2012;44:157\u201362.","journal-title":"Horm Metab Res"},{"key":"948_CR13","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1210\/jc.2016-1472","volume":"101","author":"SC Kayser","year":"2016","unstructured":"Kayser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, van der Wel MC, et al. Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis. J Clin Endocrinol Metab. 2016;101:2826\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"948_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-019-0121-0","volume":"25","author":"HC Kim","year":"2019","unstructured":"Kim HC, Ihm S-H, Kim G-H, Kim JH, Kim K-I, Lee H-Y, et al. 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension. Clin Hypertens. 2019;25:16.","journal-title":"Clin Hypertens"},{"key":"948_CR15","first-page":"254","volume":"24","author":"YS Jang","year":"2009","unstructured":"Jang YS, Kim KS, Kim HS. Comparing the prevalence of primary aldosteronism in hypertensive diabetic and non-diabetic patients. Endocrinol Metab. 2009;24:254\u20139.","journal-title":"Endocrinol Metab"},{"key":"948_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3904\/kjim.2014.29.2.217","volume":"29","author":"SH Kim","year":"2014","unstructured":"Kim SH, Ahn JH, Hong HC, Choi HY, Kim YJ, Kim NH, et al. Changes in the clinical manifestations of primary aldosteronism. Korean J Intern Med. 2014;29:217.","journal-title":"Korean J Intern Med"},{"key":"948_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3803\/EnM.2016.31.4.567","volume":"31","author":"JS Lim","year":"2016","unstructured":"Lim JS, Park S, Park SI, Oh YT, Choi E, Kim JY, et al. Cardiac dysfunction in association with increased inflammatory markers in primary aldosteronism. Endocrinol Metab. 2016;31:567.","journal-title":"Endocrinol Metab"},{"key":"948_CR18","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021\u2013104.","journal-title":"Eur Heart J"},{"key":"948_CR19","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1210\/jc.2006-0078","volume":"91","author":"P Mulatero","year":"2006","unstructured":"Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella C, et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2006;91:2618\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"948_CR20","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/HJH.0b013e328126856e","volume":"25","author":"GP Rossi","year":"2007","unstructured":"Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, et al. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens. 2007;25:1433\u201342.","journal-title":"J Hypertens"},{"key":"948_CR21","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s00270-013-0820-y","volume":"37","author":"SI Park","year":"2014","unstructured":"Park SI, Rhee Y, Lim JS, Park S, Kang SW, Lee MS, et al. Right adrenal venography findings correlated with C-arm CT for selection during C-arm CT-assisted adrenal vein sampling in primary aldosteronism. Cardiovasc Interv Radio. 2014;37:1469\u201375.","journal-title":"Cardiovasc Interv Radio"},{"key":"948_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3803\/EnM.2018.33.2.236","volume":"33","author":"CH Park","year":"2018","unstructured":"Park CH, Hong N, Han K, Kang S-W, Lee CR, Park S, et al. C-arm computed tomography-assisted adrenal venous sampling improved right adrenal vein cannulation and sampling quality in primary aldosteronism. Endocrinol Metab. 2018;33:236\u201344.","journal-title":"Endocrinol Metab"},{"key":"948_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63:151\u201360.","journal-title":"Hypertension."},{"key":"948_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S2213-8587(14)70069-5","volume":"3","author":"S Monticone","year":"2015","unstructured":"Monticone S, Viola A, Rossato D, Veglio F, Reincke M, Gomez-Sanchez C, et al. Adrenal vein sampling in primary aldosteronism: towards a standardised protocol. Lancet Diabetes Endocrinol. 2015;3:296\u2013303.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"948_CR25","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JW, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689\u201399.","journal-title":"Lancet Diabetes Endocrinol."},{"key":"948_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J-Cardiovasc Imaging. 2015;16:233\u201371.","journal-title":"Eur Heart J-Cardiovasc Imaging"},{"key":"948_CR27","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1097\/HJH.0000000000002477","volume":"38","author":"JH Jhee","year":"2020","unstructured":"Jhee JH, Seo J, Lee CJ, Park JT, Han SH, Kang S-W, et al. Ambulatory blood pressure variability and risk of cardiovascular events, all-cause mortality, and progression of kidney disease. J Hypertens. 2020;38:1712\u201321.","journal-title":"J Hypertens"},{"key":"948_CR28","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/jch.14113","volume":"23","author":"CJ Lee","year":"2021","unstructured":"Lee CJ, Ha JH, Kim JY, Kim IC, Ryu SK, Rhee MY, et al. Office blood pressure threshold of 130\/80 mmHg better predicts uncontrolled out\u2010of\u2010office blood pressure in apparent treatment\u2010resistant hypertension. J Clin Hypertens. 2021;23:595\u2013605.","journal-title":"J Clin Hypertens"},{"key":"948_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/00004872-200305000-00001","volume":"21","author":"E O\u2019brien","year":"2003","unstructured":"O\u2019brien E, Asmar R, Beilin L, Imai Y, Mallion J-M, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821\u201348.","journal-title":"J Hypertens"},{"key":"948_CR30","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/HJH.0000000000000221","volume":"32","author":"G Parati","year":"2014","unstructured":"Parati G, Stergiou G, O\u2019Brien E, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32:1359\u201366.","journal-title":"J Hypertens"},{"key":"948_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40885-018-0104-6","volume":"25","author":"HC Kim","year":"2019","unstructured":"Kim HC, Ihm S-H, Kim G-H, Kim JH, Kim K-I, Lee H-Y, et al. 2018 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology of hypertension. Clin Hypertens. 2019;25:1\u20136.","journal-title":"Clin Hypertens"},{"key":"948_CR32","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"948_CR33","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2020.02.052","volume":"75","author":"Z Xu","year":"2020","unstructured":"Xu Z, Yang J, Hu J, Song Y, He W, Luo T, et al. Primary aldosteronism in patients in China with recently detected hypertension. J Am Coll Cardiol. 2020;75:1913\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"948_CR34","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","volume":"34","author":"P Mulatero","year":"2016","unstructured":"Mulatero P, Monticone S, Burrello J, Veglio F, Williams TA, Funder J. Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J Hypertens. 2016;34:2253\u20137.","journal-title":"J Hypertens"},{"key":"948_CR35","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","volume":"75","author":"G Jaffe","year":"2020","unstructured":"Jaffe G, Gray Z, Krishnan G, Stedman M, Zheng Y, Han J, et al. Screening rates for primary aldosteronism in resistant hypertension: a cohort study. Hypertension. 2020;75:650\u20139.","journal-title":"Hypertension"},{"key":"948_CR36","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension. 2006;48:232\u20138.","journal-title":"Hypertension"},{"key":"948_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","volume":"52","author":"ML Muiesan","year":"2008","unstructured":"Muiesan ML, Salvetti M, Paini A, Agabiti-Rosei C, Monteduro C, Galbassini G, et al. Inappropriate left ventricular mass in patients with primary aldosteronism. Hypertension. 2008;52:529\u201334.","journal-title":"Hypertension"},{"key":"948_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1530\/EJE-15-0450","volume":"173","author":"G Hanslik","year":"2015","unstructured":"Hanslik G, Wallaschofski H, Dietz A, Riester A, Reincke M, Allolio B, et al. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry. Eur J Endocrinol. 2015;173:665\u201375.","journal-title":"Eur J Endocrinol"},{"key":"948_CR39","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2337\/dc18-1293","volume":"42","author":"Y Akehi","year":"2019","unstructured":"Akehi Y, Yanase T, Motonaga R, Umakoshi H, Tsuiki M, Takeda Y, et al. High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan. Diabetes Care. 2019;42:938\u201345.","journal-title":"Diabetes Care"},{"key":"948_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00004872-200018010-00004","volume":"18","author":"Y Kimura","year":"2000","unstructured":"Kimura Y, Kawamura M, Onodera S, Hiramori K. Controlled study of circadian rhythm of blood pressure in patients with aldosterone-producing adenoma compared with those with essential hypertension. J Hypertens. 2000;18:21\u20135.","journal-title":"J Hypertens"},{"key":"948_CR41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/cen.14373","volume":"94","author":"R Libianto","year":"2021","unstructured":"Libianto R, Menezes S, Kaur A, Gwini SM, Shen J, Narayan O, et al. Comparison of ambulatory blood pressure between patients with primary aldosteronism and other forms of hypertension. Clin Endocrinol. 2021;94:353\u201360.","journal-title":"Clin Endocrinol"},{"key":"948_CR42","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1524-6175.2006.05712.x","volume":"8","author":"M Ceruti","year":"2006","unstructured":"Ceruti M, Petramala L, Cotesta D, Cerci S, Serra V, Caliumi C, et al. Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases. J Clin Hypertens. 2006;8:642\u20138.","journal-title":"J Clin Hypertens"},{"key":"948_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.jhh.1001644","volume":"18","author":"T Zelinka","year":"2004","unstructured":"Zelinka T, \u0160trauch B, Pecen L, Widimsk\u00fd J. Diurnal blood pressure variationin pheochromocytoma, primary aldosteronism and Cushing\u2019s syndrome. J Hum Hypertens. 2004;18:107\u201311.","journal-title":"J Hum Hypertens"},{"key":"948_CR44","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s12020-021-02606-3","volume":"72","author":"Q Wu","year":"2021","unstructured":"Wu Q, Hong M, Xu J, Tang X, Zhu L, Gao P, et al. Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism. Endocrine. 2021;72:835\u201343.","journal-title":"Endocrine."},{"key":"948_CR45","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1161\/HYPERTENSIONAHA.107.109439","volume":"51","author":"AW Krug","year":"2008","unstructured":"Krug AW, Ehrhart-Bornstein M. Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor? Hypertension. 2008;51:1252\u20138.","journal-title":"Hypertension."},{"key":"948_CR46","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.117.10238","volume":"71","author":"K Kario","year":"2018","unstructured":"Kario K, Chen C-H, Park S, Park C-G, Hoshide S, Cheng H-M, et al. Consensus document on improving hypertension management in Asian patients, taking into account Asian characteristics. Hypertension. 2018;71:375\u201382.","journal-title":"Hypertension."},{"key":"948_CR47","first-page":"2854","volume":"85","author":"K-C Loh","year":"2000","unstructured":"Loh K-C, Koay ES, Khaw M-C, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000;85:2854\u20139.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00948-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00948-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00948-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,13]],"date-time":"2022-11-13T23:05:48Z","timestamp":1668380748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-022-00948-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1038\/s41440-022-00948-7","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CJL has received honoraria from Novartis, Daewoong Pharmaceutical, Servier, Hanmi Pharmaceutical, Yuhan, Boryung Pharmaceutical, and Daiichi Sankyo. YR has received an honorarium from Amgen and has been a consultant for Amgen and Pharmanovia. SP has received honoraria from Pfizer, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo, and Daewon. SP has also received a research grant from Daiichi Sankyo. The remaining authors have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}